| |
|

Chemical
name1-(Isopropyl
amino)-3-(1-naphthyloxy)-2-propanol hydrochloride.
Category
Beta blocker.
Mechanism of
action
It is a nonselective beta - adrenergic receptor blocking
agent, it specifically competes with beta-adrenergic receptor stimulating
agents for available receptor sites and when the sites are blocked, the
chronotropic, intropic, and vasodilator responses to beta - adrenergic
stimulation are decreased proportionately.
Indications
Propranolol is used in the management of hypertension,
phaeochromocytoma, angina pectoris, myocardial infarction and cardiac
arrhythmias. It is also used in hypertrophic subaortic stenosis. It is
used to control symptoms of sympathetic overactiuity in the management of
hyperthyroidism, anxiety disorders, and tremor. Other indications include
the prophylaxis of migraine and upper gastro - intestinal bleeding in
patients with portal hypertension.
Precautions to
consider
Propranolol is contraindicated in cardiogenic shock,
sinus bradycardia and greater than first degree block, bronchial asthma,
congestive heart failure unless the failure is secondary to a
tachyarrhythmia. Beta - adrenergic blockade may prevent the appearance
of certain premonitory signs and symptoms of acute hypoglycemia in labile
insulin - dependent diabetes. Beta blockade may mask certain clinical
signs of hyperthyroidism, therefore, abrupt withdrawal of Propranolol may
be followed by an exacerbation of symptoms of hyperthyroidism. Propranolol
should be used with caution in patients with impaired hepatic or renal
function.
Pregnancy
Category - C
Breast -
feeding
Propranolol is excreted in human milk. Caution should be
exercised when Propranolol is administered to a nursing woman.
Drug
interactions
Coadministration of catecholamin - depleting drugs such
as reserpine with Propranolol may produce an excessive reduction of
resting sympathetic nervous activity. Coadministration of a calcium -
channel blocking drug, especially intravenous verapamil with Propranolol
may depress myocardial contractility or atrioventricular conduction.
Blunting of the antihypertensive effect of Propranolol by NSAIDs has beeb
reported. Alominium hydroixde gel and Ethanol reduce intestinal absorption
of Propranolol. Cimetidine decreases the hepatic metabolism of
Propranolol.
Side / Adverse
effects
Bradycardia, congestive heart failure, intensification of
AV block, hypotention, paresthesia of hands;light - headedness , mental
depression; Gastrointestinal symptoms; Allergic reactions; Bronchospasm;
Agranulocytosis, nonthrombo cytopenic purpura, thrombocytopenic purpura.
Administration and
dosage
In hypertension Propranolol is given in initial doses of
40 mg to 80 mg twice daily increased as required to a usual range of 160
to 320 mg daily. In angina, initial doses of Propranolol 40 mg given 2
or 3 times daily are increased as required to a usual range of 120 to 240
mg daily. Propranolol is administered within 5 to 21 days of myocardial
infarction in doses of 40 mg given four times daily for 2 or 3 days
followed by 80 mg twice daily. Propranolol may be given in doses of 30
to 160 mg daily in divided doses in the long - term management of cardiac
arrhythmias. In hyperthyroidism Propranolol is given in doses of 10 to
40 mg 3 or 4 times daily. Propranolol has been used in the treatment of
hypertension in children in initial doses of 1 mg per kg body - weight
daily in divided doses by mouth. For arrhythmias, phaeochromocytoma, and
hyperthyroidism, the suggested dose is 250 to 500 μg per kg 3 or 4 times
daily.
How
suppliedTablets: Box of 100
tablets. Each tablet contains 10 mg Propranolol.
StorageStore below 30° C, protect from light and
moisture.
References1 - PDR (2002), Vol. 3, page: 3377-3380 2
- Martindale 32nd edition Vol. 1, page: 937
|